Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life by Nasi, Milena et al.
 Aging Cell
 
 (2006) 
 
5
 
, pp167–175 Doi: 10.1111/j.1474-9726.2006.00204.x
© 2006 The Authors
Journal compilation © Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2006
 
167
 
Blackwell Publishing Ltd
Thymic output and functionality of the IL-7/IL-7 
receptor system in centenarians: implications for 
the neolymphogenesis at the limit of human life
 
Milena Nasi,
 
1
 
* Leonarda Troiano,
 
1
 
* Enrico Lugli,
 
1
 
 
Marcello Pinti,
 
1
 
 Roberta Ferraresi,
 
1
 
 Elena Monterastelli,
 
1
 
 
Chiara Mussi,
 
2
 
 Gianfranco Salvioli,
 
2
 
 
Claudio Franceschi
 
3,4
 
 and Andrea Cossarizza
 
1
 
1
 
Department of Biomedical Sciences, Section of General Pathology, 
University of Modena and Reggio Emilia School of Medicine, via 
Campi 287, 41100 Modena, Italy 
 
2
 
Department of Internal Medicine, Section of Gerontology, 
University of Modena and Reggio Emilia School of Medicine, 
Ospedale Estense, Modena, Italy 
 
3
 
Department of Experimental Medicine, Section of Microbiology, 
University of Bologna School of Medicine, via San Giacomo 12, 
40126 Bologna, Italy 
 
4
 
National Institute of Aging, INRCA, Ancona, Italy 
 
Summary
 
During aging, the thymus undergoes a marked involution
that is responsible for profound changes in the T-cell com-
partment. To investigate the capacity of the thymus to
produce new cells at the limit of human lifespan, we ana-
lyzed some basic mechanisms responsible for the renewal
and maintenance of peripheral T lymphocytes in 44 cen-
tenarians. Thymic functionality was analyzed by the
quantification of cells presenting the T-cell receptor re-
arrangement excision circles (TREC). A new method based
upon real-time PCR was used, and we found that most
centenarians (84%) had undetectable levels of TREC+
cells. Six-color cytofluorimetric analysis revealed that cen-
tenarians had an extremely low number of naïve T cells;
central memory and effector memory T cells were greatly
increased, while terminally differentiated cells were as
numerous as in young (aged 20–45) or middle-aged (aged
58–62) donors. Interleukin (IL)-7 and IL-7 receptor α
 
-chain
(CD127) levels were the same at all ages, as shown by
ELISA, flow cytometry and real-time PCR. However, IL-7
plasma levels were higher in centenarian females than
males. The presence of TREC+ cells and of very few naïve
T lymphocytes suggests that in centenarians such cells
could either derive from residues of thymic lymphopoietic
islets, or even represent long-living lymphocytes that
have not yet encountered their antigen. IL-7 could be one
of the components responsible, among others, for the higher
probability of reaching extreme ages typical of females.
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Introduction
 
Several studies have demonstrated that immunological aging,
defined as immunosenescence, is not characterized by a simple
deterioration of the immune system but is part of a 
 
continuum
 
of developmental processes with complex reorganizational events,
compensatory mechanisms and qualitative alterations in function.
Centenarians provide the best example of successful aging and
their immune system is characterized by an extensive remodeling
where some parameters increase, others decrease, while some
remain unchanged (Cossarizza 
 
et al
 
., 1992; Franceschi 
 
et al
 
., 1995;
Franceschi 
 
et al
 
., 1996; Haynes 
 
et al
 
., 2000; Pinti 
 
et al
 
., 2003).
Immunological aging is characterized by profound modifications
of the thymus gland (Cossarizza 
 
et al
 
., 1996, 1997; Aspinall &
Andrew, 2000; Haynes 
 
et al
 
., 2000; Taub & Longo, 2005). Indeed,
shortly after birth the thymus undergoes a life-long process of
involution whereby the organ is replaced by adipose tissue,
accompanied by the loss of its main immune function (i.e. the
production of T cells). Such an involution results in a reduction in
the number of constituent thymocytes with age, a consequent
shrinking of the thymus and finally a decline in the output of
naïve T cells, typical of the gland. Far advanced age is thus char-
acterized by a profound reduction and consequent exhaustion
of naïve T-cell population and by a progressive accumulation of
memory/effector T cells (Sansoni 
 
et al
 
., 1997; Fagnoni 
 
et al
 
., 2000).
The modifications in peripheral T-cell populations reflect not
only the involution of the thymus, but are also consequent upon
the massive antigenic stimulation of a virgin immune system by
numerous foreign antigens, that occurs principally between
birth and puberty. Few data exist on the origin and renewal of
virgin and memory T-cell compartments with age, especially at
a time when the thymus has undergone a profound involution,
as is the case in centenarians (Douek 
 
et al
 
., 1998; Poulin 
 
et al
 
.,
1999; Douek & Koup, 2000). The direct evaluation of thymic
output is now possible by the quantification of the so-called
‘recent thymic emigrants’ (RTE), the main cells that contribute
to the naïve T-cell pool (that have the phenotype: CD45RA+,
CD62L+, CCR7+, CD95–). RTE are characterized by the pres-
ence in the nucleus of circular episomal DNA molecules named
‘T-cell receptor (TCR) rearrangement excision circles’ (TREC) that
are generated during the rearrangement of the TCR locus, and
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that can be measured by different assays, including real-time
polymerase chain reaction (PCR) (Pinti 
 
et al
 
., 2003). Recent data
show that TREC+ cells decline with age, and indeed donors
older than 55 years have fourfold less cells than young individ-
uals (Naylor 
 
et al
 
., 2005). No data are yet available on the pro-
duction of TREC+ cells at the extreme limit of human lifespan.
The cytokine network undergoes a complex remodelling dur-
ing aging, where an increase of proinflammatory molecules has
been well documented, along with a decrease of a trophic agent
such as interleukin (IL)-2 (Fagiolo 
 
et al
 
., 1993; Bagnara 
 
et al
 
.,
2000; Franceschi 
 
et al
 
., 2000a,c; Gerli 
 
et al
 
., 2000; Franceschi
 
et al
 
., 2001). Another cytokine, IL-7, has profound effects on
the production of T lymphocytes and on the homeostasis of the
T-cell pool (Fry & Mackall, 2001, 2005; Okamoto 
 
et al
 
., 2002;
Bradley 
 
et al.
 
, 2005), but scanty data exist on its production and
utilization during aging. The activity of IL-7 is mediated by a
receptor which is formed by a specific 
 
α
 
-chain (IL-7R
 
α
 
, or
CD127, expressed by most peripheral T cells), linked with the
so called 
 
γ
 
c
 
-chain, a molecule shared in common with receptors
for other cytokines such as IL-2, IL-4, IL-9, IL-15, and IL-21. The
formation of a heterodimer is crucial for signal transduction and
therefore for the activity of this cytokine. Interestingly, the pres-
ence of high amounts of IL-7 receptor is associated with the
permanent up-regulation of the antiapoptotic molecule bcl-2,
which is accompanied by the down-regulation of CD95 (Ledru
 
et al
 
., 1998; Guillemard 
 
et al
 
., 2001). By influencing intracellular
levels of molecules such as bcl-2, bcl-x
 
L
 
 and caspase-3, IL-7
preserves T cells from apoptosis induced by glucocorticoids,
by cytokine withdrawal, and by radiation (Boise 
 
et al
 
., 1995;
Hernandez-Caselles 
 
et al
 
., 1995; Seki 
 
et al
 
., 1995; Vella 
 
et al
 
.,
1997; Hassan & Reen, 1998; Vella 
 
et al
 
., 1998). IL-7 can induce
strong telomerase activity in CD45RA+ T cells without the
requirement of TCR stimulation. It has been suggested that this
cytokine-mediated expansion may contribute to the main-
tenance of a naïve T-cell repertoire in adults (Soares 
 
et al
 
., 1998).
In order to investigate thymic functionality and the IL-7/IL-7
receptor system during human longevity, we have analyzed the
expression of TREC, IL-7 receptor and plasma levels of IL-7 in a
group of 44 centenarians, who have been compared to young
and middle-aged donors.
 
Results
 
Distribution of naïve, central and effector memory, 
and terminally differentiated lymphocytes in 
centenarians
 
Using flow cytometry, we measured the percentages of naïve,
central and effector memory, and terminally differentiated cells
in highly defined CD4+ and CD8+ T cells from 10 centenarians,
11 middle-aged and 12 young subjects. A typical example of
the analysis performed on a centenarian’s lymphocyte sample
is shown in Fig. 1. To better identify CD4+ and CD8+ T lym-
phocytes, we first gated cells on the basis of their physical
parameters (FSC and SSC), then on the basis of CD45 and CD3
expression. A gate was then set on CD4+ or CD8+ lymphocytes,
Fig. 1 Cytofluorimetric analysis of PBMC in a centenarian. In this representative example, a first gate was set on FSC vs. SSC to identify small lymphocytes 
and to eliminate cell debris. T cells were identified by gating on CD45+, CD3+ cells. The expression of CD45RA and CCR7 was then investigated in CD4+ and 
CD8+ cells.
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and the expression of CD45RA and CCR7 was analyzed on each
main T-cell subset. Quadrants were drawn on the basis of ad-
equate negative controls.
Figure 2 shows the results obtained in the three populations
under investigation. It is noteworthy that while main changes
occurred in the naïve, central memory and effector memory
compartment, no significant age-related changes were present
in the compartment of terminally differentiated cells either
among CD4+ or CD8+ T cells.
 
Quantification of sjTREC+ cells
 
The evaluation of sjTREC levels was performed on peripheral
blood mononuclear cells (PBMC) of 16 young subjects (13
females and 3 males), 13 middle-aged subjects (10 females, 3
males) and 25 centenarians (22 females and 3 males). All young
subjects had detectable levels of TREC, which were undetectable
in 3 out of 13 middle-aged donors and in 21 out of 25 cente-
narians (
 
P <
 
 0.0001 by chi-squared).
As far as the donors with detectable levels of TREC are con-
cerned, we have observed an age-related significant decline of
the number of sjTREC+ cells (
 
P =
 
 0.012 by Kruskal–Wallis test).
Indeed, Fig. 3 indicates that young donors showed high levels
of sjTREC+ cells (mean 
 
±
 
 SEM: 3.20% 
 
±
 
 0.48%) while middle-
aged subjects had 2.13 
 
±
 
 0.47% sjTREC+ cells, and centenarians
0.26 
 
±
 
 0.20% sjTREC+ cells. The comparison between young
and middle-aged groups revealed that there was no significant
difference (
 
P
 
 > 0.05 by Dunn’s Multiple Comparison test). A
statistical difference was observed comparing the groups of
young and centenarian donors (
 
P <
 
 0.01); probably because of
the low number of centenarians, no differences were present
between these subjects and middle-aged donors.
 
IL-7 plasma concentration in males and females
 
We quantified IL-7 plasma levels in 29 young donors (15 females
and 14 males), 31 middle-aged donors (16 females and 15
males) and 44 centenarians (24 females and 20 males). In the
three groups, IL-7 plasma concentrations were 5.68 
 
±
 
 0.94,
5.32 
 
± 
 
0.77, and 5.13 
 
±
 
 0.67 pg mL
 
−
 
1
 
 (mean 
 
±
 
 SEM), respec-
tively. Thus, if data from all subjects are considered together,
plasma levels of IL-7 do not change with aging. We then ana-
lyzed plasma IL-7 levels in males and females separately (Fig. 4),
and observed that IL-7 does not change significantly with age.
However, the comparison between males and females in the
three classes of age revealed a significant gender difference in
centenarians, where values obtained in females were higher
than those in males (
 
P =
 
 0.044). No correlation was found
between plasma IL-7 levels and TREC+ cells.
 
Analysis of CD127 expression at the cellular and 
molecular level
 
In seven donors per group, we could analyze the expression
of CD127 on the surface of CD4+ and CD8+ T cells. Figure 5
shows a representative example of cytofluorimetric analysis. The
Fig. 2 Naïve and memory T cells in centenarians, 
young and middle-aged donors. Data indicate the 
percentages (mean ± SEM) of CD4+ and CD8+ 
naïve (CD45RA+CCR7+), central memory 
(CD45RA–CCR7+), effector memory (CD45RA–
CCR7–) and terminal effector (CD45RA+CCR7–) T 
cells in young (Y), middle-aged (MA) and 
centenarian (C) subjects.*P < 0.05, **P < 0.01, 
***P < 0.001 compared to young healthy donors.
Fig. 3 Changes in TREC+ cells with age. The percentage of sj-TREC positive 
cells undergoes a dramatic age-dependent decline from young to middle-
aged subjects and centenarians. Kruskal–Wallis test among the three groups 
revealed a P < 0.0001. No significant difference was observed between young 
and middle-aged donors. Note that only the values from individuals with 
detectable TREC levels (all young subjects, 10 out of 13 middle-aged donors, 
4 out of 25 centenarians) are shown here.
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mean percentage of CD127+ cells in CD4+ was 87.77 
 
±
 
 2.33
in young donors, 87.84 
 
±
 
 1.72 in middle-aged donors and
88.80 
 
±
 
 2.29 in centenarians. CD8+ cells expressing CD127
were 84.74 
 
±
 
 3.95, 85.63 
 
± 
 
2.78, and 86.67 
 
±
 
 1.01, respectively.
Thus, the percentage of CD127+ T lymphocytes does not change
with age either in CD4+ or in CD8+ cells.
To confirm the data regarding protein expression with the
quantification of mRNA that code for the 
 
α
 
 chain of the IL-7
receptor in these donors, we analyzed CD127 mRNA levels in
resting PBMC (Fig. 6, upper panel) from 6 young and 6 middle-
aged donors and 5 centenarians. Then, to evaluate whether
mRNA production was also maintained in activated cells during
aging, we treated lymphocytes with classical stimuli such as
anti-CD3 mAbs or ionomycin plus TPA (Fig. 6, middle and lower
panels, respectively). No differences between young and middle-
aged donors, and centenarians were found in cells treated with
anti-CD3 mAbs, that had a minimal effect on mRNA produc-
tion. However, when a maximal stimulus for mRNA synthesis
such as ionomycin plus TPA was applied, we found a statistically
significant effect of age (
 
P =
 
 0.0084); young donors showed
significantly higher values than middle-aged donors or cen-
tenarians (
 
P <
 
 0.01 and 
 
P
 
 < 0.02, respectively). No correlation
was found between CD127 mRNA expression and TREC levels.
 
Discussion
 
The aim of this study was to investigate the behaviour of crucial
parameters related to the homeostasis of T lymphocytes during
human immunosenescence. By measuring TREC+ cells in
Fig. 4 Plasma interleukin-7 levels in the groups studied. Data refer to the 
plasma levels of IL-7 in young (Y), middle-aged (MA) and centenarians (C). 
We performed a gender-specific analysis by dividing the three populations 
in males and females, and observed a significant gender difference only in 
centenarians.
Fig. 5 Cytofluorimetric analysis of CD127 expression in cells from a centenarian. Representative example of the cytometric analysis of CD127 expression on 
CD4+ and CD8+ T cells from a centenarian. First, CD45+ cells were gated, then T cells were identified by gating on CD3+ cells. Another gate was subsequently 
done either on CD4+ or CD8+ T cells. The percentage of CD127+ cells was calculated taking into account the adequate fluorescence background (BKG).
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centenarians, we have analyzed the capacity of the thymus to pro-
duce new lymphocytes at the limit of human lifespan, and then we
have investigated the functionality of the IL-7/IL-7 receptor system.
Previous studies have shown that an age-related reduction
in virgin cells exists among CD4+ and CD8+ T lymphocytes, and
this is also the case with centenarians (Fagnoni 
 
et al
 
., 2000).
However, these studies, could not fully analyze the different
populations of naïve and memory cells. Here we show that sub-
stantial changes occur with age in the compartment of naïve,
central and effector memory lymphocytes, but not in the
compartment of terminally differentiated cells, i.e. those that
re-express CD45RA on the cell surface but do not expose CCR7
or other homing receptors such as CD62L (Champagne 
 
et al
 
.,
2001). Interestingly, most of these cells express markers of cell
death/activation such as CD95 (Lugli E. 
 
et al.
 
, manuscript in
preparation). It is thus likely that these cells represent a part of
the previously reported population of CD45RA+ (virgin) cells,
mainly present within the subset of CD8+ T cells during human
aging (Cossarizza 
 
et al
 
., 1996). Terminally differentiated cells are
able to produce cytokines such as IL-2, perforin and TNF-
 
α
 
 that
are crucial for several functions, including triggering of proliferative
events or the control of infectious agents. This could indicate
that the immune system has to maintain a fixed percentage of
cells capable of performing the final step of the immune
response until the extreme limit of human life.
The decrease in the number of naïve T cells was accompanied
by a dramatic reduction in the functionality of the thymus, as
revealed by the quantification of TREC+ cells. In most cen-
tenarians we could not detect any TREC molecules; since the
methodology we used has an estimated sensitivity of about 1
cell in 20 000 (since in each PCR tube the DNA equivalent
of 20 000 cells is amplified), it cannot be excluded that the
frequency of TREC+ cells was lower than this value. In any case,
a detectable number of TREC+ lymphocytes that can be defined
as ‘recent thymic emigrants’ were indeed present in few of
them. It is well known that the thymus loses its capacity to gen-
erate T cells after puberty, and that the involution is clearly max-
imal at extreme advanced ages (Pawelec 
 
et al
 
., 2002; Franceschi
& Bonafe, 2003). It is generally thought that, when the thymus
progressively undergoes the profound age-related involution,
the output of naïve T cells is not sufficient to maintain the size
of the peripheral naïve T-cell pool. Thus (yet) unknown mech-
anisms, including the capacity of forming T cells in sites other
than the thymus, have been hypothesized (Abo, 2001).
Our data show that minimal amounts of sjTREC+ cells can
be present in centenarians. This observation has two possible,
not mutually exclusive, interpretations. The first is that a minimal
functional capacity of the thymus still exists, and is likely respon-
sible for the output of naïve T lymphocytes. Previous studies
have shown that TREC+ cells were detected in elderly people
(up to 78 years), indicating the presence of a continuous thymic
output of TREC+ naïve T cells even in aged subjects, who were,
however, 20–25 years younger than those we analyzed (Douek
 
et al
 
., 1998). These naïve T cells could derive from residues of
thymic lymphopoietic islets, and indeed it has been demon-
strated that the relative number of TREC+ cells present within
thymocytes isolated from healthy donors is constant with
increasing age despite the age-related involution of thymic
tissue and the consequent loss in the total number of thymo-
cytes. Thus, diminished thymic output would lower the number
of naïve T cells produced, but does not change the amount of
TREC+ cells within RTE (Jamieson 
 
et al
 
., 1999). It should be
emphasized that the age-related decrease in the amount of
TREC+ cells can be due not only to a decreased thymic function,
but also to an expansion of T cells in the periphery (Hazenberg
 
et al
 
., 2001, 2003). Indeed, it is well known that with age the
number of activated peripheral T cells increases, along with the
presence of expanded T-cell clones (Sansoni 
 
et al
 
., 1993; Wack
 
et al
 
., 1998). The sum of T-cell activation and proliferation can
thus contribute, at least in part, to the decrease in TREC that
we have found in centenarians.
A second possible explanation is that TREC+ cells have an
extremely long lifespan. In a group of patients thymectomized
3–39 years prior to analysis, TREC+ cells were detectable, even
if their number was one order of magnitude lower than healthy
controls (Douek 
 
et al
 
., 1998). Clearly, such cells were not recently
produced by the thymus, but were likely those produced when
the thymus was still present. As a consequence, the detection
of TRECs in adults or aged individuals cannot be taken as an
absolute measure of thymic activity, but is the sum of a residual
thymic function and the presence of life-long naïve T cells, that
could mask for many years the absence of a thymic output.
Fig. 6 Expression of CD127 mRNA in cells from the studied groups. Data 
indicate the amount of copies of CD127 mRNA per 1000 copies of HBP mRNA 
in PBMC from young (Y), middle-aged (MA) and centenarians (C) without 
any stimulation (basal, upper panel) and after stimulation with anti-CD3 mAb 
(middle panel) and TPA plus ionomycin (lower panel). A significant difference 
was observed only with the last treatment, in middle-aged vs. young donors 
(*P < 0.01).
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IL-7 is a crucial molecule for the immune system. Not only
does it have a trophic action on precursor T cells, but it can
also act as a survival factor for mature T lymphocytes, and fur-
ther on the survival of naïve T cells (Fry 
 
et al
 
., 2001). There is
evidence that IL-7 has a nonredundant role in supporting not
only survival but also homeostatic expansion of naïve CD4+ and
CD8+ T cells 
 
in vivo
 
 (Rathmell 
 
et al
 
., 2001). IL-7 is also a potent
modulator of thymus-independent T-cell regeneration and
extrathymic maturation (Laky 
 
et al
 
., 1998, 2000). It is thus log-
ical that the production of this cytokine should be kept constant
throughout life, and indeed we observed that IL-7 plasma levels
did not change significantly among young or adult donors and
centenarians. However, we found that, in centenarians, females
had higher IL-7 levels than males. In general, among centenarians,
women outnumber men all over the world. In Italy, a gradient
exists from north to south, and the ratio between women and
men decreases from about 7 : 1 in northern Italy to 3 : 1 in
southern Italy (Passarino 
 
et al
 
., 2002). In some areas, such as the
province of Nuoro in the island of Sardinia, this ratio is as low
as 1 : 1 (Deiana 
 
et al
 
., 1999). The reasons for such a gradient
are at present unknown, and differences related to differential
mortality in women and men, as well as those related to social,
genetic and anthropological factors, may play a role (Franceschi
et al., 2000b). For these reasons we have compared females and
males, and found a higher IL-7 plasma level in women.
To further investigate the IL-7/IL-7 receptor system, we have
analyzed the expression of CD127 at the cellular and molecular
level, and found that CD127 was expressed at a constant rate
on resting CD4+ and CD8+ surface throughout life. This was
confirmed by the quantitative analysis of mRNA expression,
which remained stable even after the stimulation of TCR with
anti-CD3 mAbs. Treating resting lymphocytes with ionomycin
and TPA resulted in a significant decrease in the production of
CD127 mRNA both in middle-aged donors and in centenarians.
This could indicate that the capacity to respond to a maximal
stimulus with the massive production of CD127 mRNA is lost
in middle-aged individuals, long before reaching the end of their
life.
The meaning of the gender-related difference in IL-7 plasma
levels is not clear since there is no difference in surface expres-
sion of CD127. A better preservation of the IL-7/IL-7R system
in females can be hypothesized that can reflect a higher efficacy
in maintaining T-cell homeostasis. In any case, the data relating
to the IL-7/IL7-R system suggest that the ability of peripheral
lymphocytes to respond to IL-7 is well preserved during aging.
Further studies are needed to clarify whether IL-7 contributes
to our understanding of the female gender-related higher prob-
ability of reaching extreme ages.
Experimental procedures
Patients and cells
We studied a total of 44 centenarians with a mean age of
100 years (range: 98–105), 20 males and 24 females. All these
subjects were in relatively good condition without relevant
acute or chronic disease affecting the immune system, and gave
informed consent for the studies here described.
As controls, we have studied two groups of healthy subjects
of different ages: 31 middle-aged subjects with a mean age of
60 years (range: 58–62, 16 males and 15 females), and 29
young donors with a mean age of 22 years (range: 20–25, 14
males and 15 females). All subjects were enrolled and selected
according to the criteria described in the SENIEUR protocol
(Ligthart et al., 1990; Gueresi et al., 2003).
Peripheral blood mononuclear cells (PBMC) were separated
from freshly collected blood according to standard procedures.
Cytofluorimetric analysis
To quantify the main populations of virgin and memory cells
(i.e. naïve, central memory, effector memory, terminally differ-
entiated) (Sallusto et al., 1999), we used a cytometric approach
with fluorochrome-labelled monoclonal antibodies (mAbs),
according to standard methods (Cossarizza et al., 2004). Frozen
PBMC (1 × 106) from young (n = 12), middle-aged (n = 11)
healthy donors and centenarians (n = 10) were thawed, washed
twice with cold Hanks’ balanced salt solution, resuspended in
100 µL PBS and stained with the following mAbs: anti-CD45
(conjugated with APC), anti-CD3 (APC-Cy7), anti-CD4 (PE-Cy5),
anti-CD8 (PE), anti-CD45RA (FITC) and anti-CCR7 (PE-Cy7);
mAbs were from Serotec (Oxford, UK), R&D Systems (Minne-
apolis, MN, USA) and BD Biosciences (San José, CA, USA). For
the analysis of the expression of CD127, we used PE-conjugated
anti-CD127 mAbs (R & D Systems), along with anti-CD4 (PE-
Cy5), anti-CD45 (APC), anti-CD8 (FITC) and anti-CD3 (APC-Cy7)
mAbs. Negative controls were prepared by incubating cells with
fluorochrome-labelled isotype-matched mAbs directed against
irrelevant antigens, according to standard procedures.
Cells were incubated for 30 min at 4 °C, then washed with
PBS, resuspended in PBS containing 1% formaldehyde and ana-
lyzed by flow cytometry (Pinti et al., 2004). At least 50 000
events inside the lymphocyte gate were acquired for each
sample. Cells were analyzed using a Cyflow ML (Partec GmbH,
Münster, Germany), equipped with a blue solid state laser (λ
488 nm, 200 mW, kept at 50 mW), a red diode laser (λ 635 nm,
25 mW), a UV Mercury lamp HBO (100 long life, 100 W, not
used in this study), a green solid state laser (λ 532 nm, 100 mW,
not used in this study), and a CCD camera. Data were acquired
and analyzed by Flomax 3.0 (Partec) and WinMDI 2.8 (by Dr J.
Trotter, Scripps University, La Jolla, CA, USA) under Windows,
and FlowJo 6.3 (Treestar Inc., Ashland, OR, USA) under MacOSx.
Quantification of IL-7 plasma levels
Non-heparinized plasma specimens (collected in EDTA) were
obtained from the subjects and stored at −80 °C until use.
Aliquots were thawed and analyzed at least in duplicate by
using a commercially available, ultrasensitive immunoassay that
detects both free IL-7 and IL-7 bound to carrier proteins or
Peripheral T-cell homeostasis during longevity, M. Nasi et al.
© 2006 The Authors
Journal compilation © Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2006
173
soluble IL-7 receptors (R&D System), following the manufacturer’s
instructions.
Detection of sjTREC+ cells
Quantification of sjTREC content was measured by an original
method that has been recently developed. This assay was per-
formed by two parallel real-time PCRs that quantify sjTREC or
nuclear DNA (nDNA) using the same construct, known amounts
of which were amplified as reference molecules. Briefly, DNA
was extracted from PBMC according to standard methods (Pinti
et al., 2002). In the first reaction, we quantified sjTREC and the
primers used were: sjDir (5′-CACATCCCTTTCAACCATGCT-3′)
and sjRev (5′-GCC AGC TGC AGG GTTTAGG-3′). The TaqMan
probe used for sjTREC (5′-FAM- ACACCTCTGGTTTTTGTAAAG
GTGCCCACT-BlackHole Quencher1-3′) was included in the
reaction mixture throughout PCR as a real-time detector for
the amplified product. We prepared a mix consisting of IQ
Supermix 2X (Bio-Rad, Hercules, CA, USA), 500 nM of primers
and 200 nM of sjTREC probe. One cycle of denaturation (95 °C
for 6 min) was performed, followed by 45 cycles of amplification
(94 °C for 30 s, 58 °C for 60 s). PCR was carried out in an iCycler
Thermal cycler (Bio-Rad), and all samples were analyzed in
triplicate.
The same approach was used to quantify nDNA, which was
required to obtain the percentage of sjTREC positive cells. In this
case, primers GenDir (5′-GGCTCTGTGAGGGATATAAAGACA-3′)
and GenRev (5′-CAAACCACCCGAGCAACTAATCT-3′), designed
on FasL gene sequence, present in two copies in the human
genome (obviously, one in each chromosome), were used. The
TaqMan probe Genprobe (5′-TexasRed-CTGTTCCGTTTCCT-
GCCGGTGC-BlackHole Quencher2-3′) was included in the reac-
tion mixture throughout PCR as a real-time detector for the
amplified product. We prepared a mix consisting of IQ Supermix
2X (Bio-Rad), 600 nM of GenDir, 400 nM of GenRev and 300 nM
of Genprobe. One cycle of denaturation (95 °C for 6 min) was
performed, followed by 45 cycles of amplification (94 °C for
30 s, 60 °C for 60 s). The primers were synthesized by Operon
(Cologne, Germany).
The regions used as templates for the two amplifications (that
is, those of sjTREC and nDNA) were cloned tail to tail in a vector
(pGEM-11Z, from Promega, Madison, WI, USA), to have a ratio
of 1 : 1 of the molecules used as reference. Then, serial known
dilutions of this vector, amplified in triplicate, were included in
each PCR run to generate a standard curve from which the
relative copy number of either sjTREC or nDNA present in the
unknown samples was determined. Then, the percentage of
sjTREC positive cells was simply obtained from the ratio between
the relative values of sjTREC and nDNA (obtained vs. the same
vector), multiplied by 2 (as two copies of the nuclear gene are
obviously present in a cell) and by 100.
Considering that in each PCR determination we used an
amount of DNA that was equivalent to a maximum of 20 000
cells, the assay we used had the theoretical capacity to reveal
a percentage of TREC+ cells as low as 0.005%.
In vitro PBMC stimulation for the modulation of CD127 
mRNA production
For the analysis of CD127 mRNA expression, freshly collected
PMBC were stimulated with anti-CD3 monoclonal antibody
(mAb) (clone OKT3, IgG, 20 ng mL−1; American Type Culture
Collection, Manassas, VA, USA), or with 3 ng mL−1 12-O-tetra-
decanoylphorbol-13-acetate (TPA) plus 2 µM ionomycin (both
from Sigma Inc., St. Louis., MI, USA), for 4 h at 37 °C, in RPMI
1640 medium containing 10% fetal calf serum, 2 mM L-
glutamine, 100 IU mL−1 penicillin, 100 µg mL−1 streptomycin
(complete medium), then collected, extensively washed and
processed. Cell pellets were used for the extraction of RNA and
quantification of CD127 mRNA.
Quantification of CD127 expression
Total RNA was extracted from PBMC using RNeasy Minikit from
Qiagen (Alameda, CA, USA), following instructions supplied
by the manufacturer. One microgram of RNA was reverse
transcribed using Random hexamers, with RevertAid First strand
cDNA Synthesis Kit by Fermentas (Vilnius, Lithuania). The total
volume of reverse transcription reaction was 25 µL; 1/25 of
cDNA was used for each real-time PCR amplification that was
a multiplexing reaction. Each reaction amplifies at the same time
IL-7α mRNA and housekeeping gene L13/HBP mRNA and was
in triplicate. Expression of the messengers was calculated as
relative expression referred to 1000 copies of HBP mRNA, based
upon differences in the threshold cycle of mRNA for IL-7Rα and
threshold cycle of HBP mRNA, as described (Pinti et al., 2003).
Selected primers were: IL-7Rα Dir (5′-GAAAACAAATGGACG-
CATGTGAA-3′), IL-7Rα Rev (5′- TCAGGGATGGATCGAACTTTA-3′),
IL-7RαProbe (5′-FAM-CAGAGAAAGCTCCAACCGGCAGC–
BlackHole Quencher2-3′), HBPDir (5′-ACCGGTAGTGGATCTT-
GGCTTT-3′), HBP Rev (5′-GCTGGAAGTACCAGGCAGTGA-3′), and
HBPprobe (5′-TexasRed-TCTTTCCTCTTCTCCTCCAGGGTGGCT-
BlackHole Quencher2-3′). The primers were synthesized by
Operon (Cologne, Germany). A portion of each cDNA was used
for quantitative PCR in a 50 µL of PCR mix consisting of PCR
buffer 1× (Promega), MgCl2 3 mM, dNTPs 400 nM, 2 U Taq
polymerase, 200 nM of each primer for HBP amplification, HBP
probe 300 nM, 400 nM of each primer for IL-7Rα amplification
and IL-7Rα probe 200 nM.
Statistical analysis
Statistical analysis was performed by Kruskal–Wallis test, Dunn’s
Multiple Comparison test and chi-squared using Prism 3.03
under Windows XP. A P-value < 0.05 was considered significant.
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